Ascendis Pharma AS (A71)

137.00
-3.00(-2.14%)
  • Volume:
    0
  • Bid/Ask:
    137.00/139.00
  • Day's Range:
    137.00 - 137.00
  • Type:Equity
  • Market:Germany
  • ISIN:US04351P1012
  • WKN:A14M6X

A71 Overview

Prev. Close
140
Day's Range
137-137
Revenue
-
Open
137
52 wk Range
94.5-150
EPS
-
Volume
0
Market Cap
7.84B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
65
P/E Ratio
-
Beta
-
1-Year Change
3.01%
Shares Outstanding
56,877,723
Next Earnings Date
Apr 06, 2022
What is your sentiment on Ascendis Pharma AS?
or
Market is currently closed. Voting is open during market hours.

Ascendis Pharma AS News

Ascendis Pharma AS Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellNeutralStrong Buy
Technical IndicatorsSellSellSellSellStrong Buy
SummarySellSellSellNeutralStrong Buy

Ascendis Pharma AS Company Profile

Ascendis Pharma AS Company Profile

Employees
482

ASCENDIS PHARMA A/S is a Danish-based biopharmaceutical company, which is involved in manufacture products for rare diseases. The Company utilizes its TransCon technologies for treatment, which can be applied to existing drug therapies, including proteins, peptides and small molecules, to create prodrugs. The Company is headquartered in Copenhagen, Denmark with offices in Heidelberg, Germany and Palo Alto, California.

Read More
  • why does ascendis announce of pediatric growth hormone data ?
    0
    • I'll ***** why? 🤣
      0
  • does anyone know pediatric growth hormone 2-year data ?
    0
    • u can see my trades in facebook and twitter
      1
      • looking for shorts selling
        0
        • buying or selling?
          0
          • well look at what we have here!! ill be watching you more closely.
            0
            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.